Abingdon Health
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Abingdon Health generated cash of -$1,659,000, which is less than the previous year. Cash used in financing activities reached the amount of -$114,000 last year. Net change in cash is therefore -$1,796,000.

Cash Flow

Abingdon Health Plc (LSE:ABDX.L): Cash Flow
2018 -2.55M -357.96K 1.35M
2020 2.09M -1.93M 3.36M
2021 -12.87M -7.27M 20.74M
2023 1.00M -156K -7K
2024 -1.65M -23K -114K

ABDX.L Cash Flow Statement (2017 – 2023)

2023 2022 2020 2019 2017
Cash at beginning of period
3.23M2.39M4.38M866.15K2.03M
Operating activities
Net income
-1.27M-3.45M-6.97M-3.37M3.46M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
426K673K749K225K680.73K
Stock-based compensation expense
48K28K1.36M36K0
Deferred income tax benefit 48K28K1.36M36K0
Changes in operating assets and liabilities:
Accounts receivable, net
-297K6.64M-8.10M1.57M463.58K
Inventories
-112K205K-7.10M-373K-133.09K
Accounts payable
-335K-3.18M7.03M2.68M-388.10K
Cash generated by operating activities
-1.65M1.00M-12.87M2.09M-2.55M
Investing activities
Purchases Of Investments
-13K000-304
Investments In Property Plant And Equipment
-35K-157K-7.25M-1.65M-358.68K
Acquisitions Net
01K-24K-280K1.02K
Cash generated by investing activities
-23K-156K-7.27M-1.93M-357.96K
Financing activities
Common Stock Issued
0020.70M0538.94K
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
0-6K-251K3.50M900K
Cash used in financing activities
-114K-7K20.74M3.36M1.35M
Net Change In Cash
-1.79M839K588.75K3.52M-1.55M
Cash at end of period
1.44M3.23M4.97M4.38M476.90K
Data sourceData sourceData sourceData sourceData source